Skip to main content
. 2022 May 11;17(5):e0266752. doi: 10.1371/journal.pone.0266752

Table 1. Characteristics of subjects from the UK Biobank, COPDGene, and CAMP data.

For continuous variables, we give the mean and standard deviation (i.e. mean (sd)). Sample 1 is for FEV1 as the outcome. Sample 2 is for age at smoking cessation as the outcome and includes former smokers. Sample 3 is for FEV1 as the outcome for the subjects with the lowest 20% of FEV1.

UK Biobank COPDGene: non-Hispanic white COPDGene: African American CAMP
Sample 1, n 151,879 6,764 3,365 698
FEV1 2.77 (0.75) 2.22 (0.95) 2.29 (0.86) 1.83 (0.50)
Sex (male), n (%) 88,406 (58.21) 3,553 (52.53) 1,856 (55.16) 408 (58.45)
Age, years 56.25 (7.98) 62.02 (8.86) 54.66 (7.21) 8.85 (2.13)
BMI 27.52 (4.86) 28.68 (6.05) 29.07 (6.66) 17.78 (3.05)
Height, cm 167.84 (9.08) 169.74 (9.46) 171.01 (9.67) 132.84 (13.84)
Sample 2, n 21,142 4,104 673 -
Smoking cessation, age in years 37.03 (10.33) 50.92 (11.03) 51.51 (9.66) -
Education (college or university), n (%) 9,201 (43.52) 3,039 (74.05) 341 (50.67) -
Pack years 18.09 (14.46) 46.71 (26.96) 38.51 (22.29) -
Smoker in household, n (%) 2,338 (11.06) 3,268 (79.63) 521 (77.41) -
Age started smoking, years 17.43 (3.18) 16.95 (3.85) 17.13 (4.97) -
Sample 3, n 29,805 - - -
FEV1 1.81 (0.28) - - -
Sex (male), n (%) 26,078 (87.50) - - -
Age, years 61.00 (6.27) - - -
BMI 28.26 (5.53) - - -
Height, cm 160.77 (7.06) - - -